Prevalence of primary hyperaldosteronism in a systemic arterial hypertension league;Prevalência do hiperaldosteronismo primário em uma liga de hipertensão arterial sistêmica

Arquivos Brasileiros de Cardiologia

Volumn 92, Issue 1, 2009, Pages 37-43

  Ribeiro, Maria Jacqueline Silva ^a,b   Neto, José Albuquerque De Figueiredo ^a   Memória, Edson Viriato ^a   Lopes, Maíra De Castro ^a   Faria, Manuel Dos Santos ^a   Salgado Filho, Natalino ^a   De Oliveira, Thiara Castro ^a  

^a FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^b Renascença II ^*  (Brazil)

Author keywords

Hyperaldosteronism; Hypertension; Prevalence

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADRENAL GLAND; ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ANTIHYPERTENSIVE THERAPY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIET RESTRICTION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PREVALENCE; PRIMARY HYPERALDOSTERONISM; REST; SUPINE POSITION; UNIVERSITY HOSPITAL;

EID: 60749127860     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2009000100007     Document Type: Article

References (23)

1. Kater CE. Hiperaldosteronismo primário: novas tendências. Rev Bras Hipertens., 2002; 9: 165-73.
2. Young WF Jr. Primary aldosteronism: management issues. Ann N Y Acad Sci. 2002; 970: 61-76.
3. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004; 89: 1045-50.
4. Francishetti EA, Abreu VG. Investigações diagnósticas em hipertensão arterial - hiperaldosteronismo. In: Sociedade Brasileira de Cardiologia. I.II Hipertensão arterial: programa de educação continuada. Rio de Janeiro: Diagraphic; 2002. p. 6-7.
5. Gomez-Hernández K, Chen-Ku CH. Hiperaldosteronismo primario, una nueva perspectiva. Acta Méd Costarric. 2007; 49: 12-20.
6. Kaplan NM. Is there an unrecognized epidemic of primary aldosteronism? (Con). Hypertension. 2007; 50: 454-8.
7. Giacchetti G, Ronconi V, Lucarelli G, Boscaro M, Mantero F. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens. 2006; 24: 737-45.
8. Mosso LG, Fardella C, Montero J, Rojas P, Sánchez O, Rojas V, et al. Alta prevalência de hiperaldosteronismo primario no diagnosticado en hipertensos catalogados como esenciales. Rev Méd Chil. 1999; 127: 800-6.
9. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among asian hypertensive patients in Singapore. J Clin Endocrinol Metab. 2000; 85: 2854-9.
10. Nishizaka MK, Ubunama MP, Zaman MA, Cofield S, Calhoun DA. Validity of plasma aldosterone-to-renin activity ratio in african american and white subjects with resistant hypertension. Am J Hypertens. 2005; 18: 805-12.
11. Umpierrez GE, Cantey P, Smiley D, Palacio A, Temponi D, Luster K, et al. Primary aldosteronism in diabetic subjects with resistant hypertension. Diabetes Care. 2007; 30: 1699-703.
12. Calhoun DA. Is there an unrecognized epidemic of primary aldosteronism? (Pro). Hypertension. 2007; 50: 447-53.
13. Mulatero, P.; Rabbia, F.; Milan, A.; Paglieri, C.; Morello, F.; Chiandussi, L. et al. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002; 40: 897-908.
14. Passos VQ, Martins LAL, Pereira MAA, Kater CE. Hiperaldosteronismo primário revisitado. Arq Bras Endocrinol Metab. 2001; 45: 285-301.
15. Kater CE. Hiperaldosteronismo primário. Arq Bras Endocrinol Metab. 2002; 46: 106-15.
16. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol. 2006; 48: 2293-300.
17. Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study base don the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Rev. 2007; 30: 111-7.
18. Williams JS, Williams GH, Raji A, Jeunemaitre X, Brown NJ, Hopkins PN, et al. Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalemia. J Hum Hypertens. 2006; 20: 129-36.
19. Mulatero P, Dluhy RG, Giacchetti G, Boscaro M, Veglio F, Stewart PM. Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab. 2005; 16: 114-9.
20. Stowasser M, Gordon RD. Primary aldosteronism - careful investigation is essential and rewarding. Mol Cell Endocrinol. 2004; 217: 33-9.
21. Krakoff LR. Screening for primary aldosteronism: progress and frustration. J Hypertens. 2006; 24: 635-7.
22. Kaplan NM. The current epidemic of primary aldosteronism: causes and consequences. J Hypertens. 2004; 22: 863-9.
23. Tiu SC, Choi CH, Shek CC, Ng YW, Chan FKW, Ng CM, et al. The use of aldosterone - renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab. 2005; 90: 72-8.